OpCT-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OpCT-001, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO) [Phase 1, Phase 2]